Literature DB >> 18669861

Regulation of CD45 alternative splicing by heterogeneous ribonucleoprotein, hnRNPLL.

Shalini Oberdoerffer1, Luis Ferreira Moita, Daniel Neems, Rui P Freitas, Nir Hacohen, Anjana Rao.   

Abstract

The transition from naïve to activated T cells is marked by alternative splicing of pre-mRNA encoding the transmembrane phosphatase CD45. Using a short hairpin RNA interference screen, we identified heterogeneous ribonucleoprotein L-like (hnRNPLL) as a critical inducible regulator of CD45 alternative splicing. HnRNPLL was up-regulated in stimulated T cells, bound CD45 transcripts, and was both necessary and sufficient for CD45 alternative splicing. Depletion or overexpression of hnRNPLL in B and T cell lines and primary T cells resulted in reciprocal alteration of CD45RA and RO expression. Exon array analysis suggested that hnRNPLL acts as a global regulator of alternative splicing in activated T cells. Induction of hnRNPLL during hematopoietic cell activation and differentiation may allow cells to rapidly shift their transcriptomes to favor proliferation and inhibit cell death.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18669861      PMCID: PMC2791692          DOI: 10.1126/science.1157610

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  21 in total

1.  A model system for activation-induced alternative splicing of CD45 pre-mRNA in T cells implicates protein kinase C and Ras.

Authors:  K W Lynch; A Weiss
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

2.  A genomic view of alternative splicing.

Authors:  Barmak Modrek; Christopher Lee
Journal:  Nat Genet       Date:  2002-01       Impact factor: 38.330

Review 3.  Mechanisms of alternative pre-messenger RNA splicing.

Authors:  Douglas L Black
Journal:  Annu Rev Biochem       Date:  2003-02-27       Impact factor: 23.643

Review 4.  CD45: a critical regulator of signaling thresholds in immune cells.

Authors:  Michelle L Hermiston; Zheng Xu; Arthur Weiss
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

5.  Ribonomics: identifying mRNA subsets in mRNP complexes using antibodies to RNA-binding proteins and genomic arrays.

Authors:  Scott A Tenenbaum; Patrick J Lager; Craig C Carson; Jack D Keene
Journal:  Methods       Date:  2002-02       Impact factor: 3.608

6.  Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays.

Authors:  Jason M Johnson; John Castle; Philip Garrett-Engele; Zhengyan Kan; Patrick M Loerch; Christopher D Armour; Ralph Santos; Eric E Schadt; Roland Stoughton; Daniel D Shoemaker
Journal:  Science       Date:  2003-12-19       Impact factor: 47.728

Review 7.  Consequences of regulated pre-mRNA splicing in the immune system.

Authors:  Kristen W Lynch
Journal:  Nat Rev Immunol       Date:  2004-12       Impact factor: 53.106

Review 8.  Understanding alternative splicing: towards a cellular code.

Authors:  Arianne J Matlin; Francis Clark; Christopher W J Smith
Journal:  Nat Rev Mol Cell Biol       Date:  2005-05       Impact factor: 94.444

9.  Alternatively spliced isoforms of a novel stromal RNA regulating factor.

Authors:  I Shur; D Ben-Avraham; D Benayahu
Journal:  Gene       Date:  2004-06-09       Impact factor: 3.688

Review 10.  CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development.

Authors:  I S Trowbridge; M L Thomas
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

View more
  104 in total

1.  Protein Kinase C Theta Modulates PCMT1 through hnRNPL to Regulate FOXP3 Stability in Regulatory T Cells.

Authors:  E Ilker Ozay; Sudarvili Shanthalingam; Joe A Torres; Barbara A Osborne; Gregory N Tew; Lisa M Minter
Journal:  Mol Ther       Date:  2020-06-15       Impact factor: 11.454

Review 2.  Next-generation genomics: an integrative approach.

Authors:  R David Hawkins; Gary C Hon; Bing Ren
Journal:  Nat Rev Genet       Date:  2010-07       Impact factor: 53.242

3.  A conserved role for intragenic DNA methylation in alternative pre-mRNA splicing.

Authors:  Shalini Oberdoerffer
Journal:  Transcription       Date:  2012 May-Jun

4.  TET-catalyzed oxidation of intragenic 5-methylcytosine regulates CTCF-dependent alternative splicing.

Authors:  Ryan J Marina; David Sturgill; Marc A Bailly; Morgan Thenoz; Garima Varma; Maria F Prigge; Kyster K Nanan; Sanjeev Shukla; Nazmul Haque; Shalini Oberdoerffer
Journal:  EMBO J       Date:  2015-12-28       Impact factor: 11.598

5.  Low-Affinity Memory CD8+ T Cells Mediate Robust Heterologous Immunity.

Authors:  Scott M Krummey; Ryan J Martinez; Rakieb Andargachew; Danya Liu; Maylene Wagener; Jacob E Kohlmeier; Brian D Evavold; Christian P Larsen; Mandy L Ford
Journal:  J Immunol       Date:  2016-02-10       Impact factor: 5.422

6.  Identification of Tat-SF1 cellular targets by exon array analysis reveals dual roles in transcription and splicing.

Authors:  Heather B Miller; Timothy J Robinson; Raluca Gordân; Alexander J Hartemink; Mariano A Garcia-Blanco
Journal:  RNA       Date:  2011-01-31       Impact factor: 4.942

7.  A splicing component adapted to gene silencing.

Authors:  Xavier Roca; Adrian R Krainer
Journal:  Nat Biotechnol       Date:  2009-03       Impact factor: 54.908

8.  An RNAi screen for Aire cofactors reveals a role for Hnrnpl in polymerase release and Aire-activated ectopic transcription.

Authors:  Matthieu Giraud; Nada Jmari; Lina Du; Floriane Carallis; Thomas J F Nieland; Flor M Perez-Campo; Olivier Bensaude; David E Root; Nir Hacohen; Diane Mathis; Christophe Benoist
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-16       Impact factor: 11.205

Review 9.  CD45, CD148, and Lyp/Pep: critical phosphatases regulating Src family kinase signaling networks in immune cells.

Authors:  Michelle L Hermiston; Julie Zikherman; Jing W Zhu
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

10.  RNA interference screen in primary human T cells reveals FLT3 as a modulator of IL-10 levels.

Authors:  Anne L Astier; Gaëlle Beriou; Thomas M Eisenhaure; Stephen M Anderton; David A Hafler; Nir Hacohen
Journal:  J Immunol       Date:  2009-12-16       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.